List of works - Ulrich Budde

A common origin of the 4143insA ADAMTS13 mutation

scientific article

ADAMTS-13 regulates platelet adhesion under flow. A new method for differentiation between inherited and acquired thrombotic thrombocytopenic purpura.

scientific article

Acquired von Willebrand syndrome: experience from 2 years in a single laboratory compared with data from the literature and an international registry

scientific article

Addition of in-vitro generated endothelial microparticles to von-Willebrand plasma improves primary and secondary hemostasis ⬇️

scientific article published on December 6, 2013

Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences

scientific article

Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease

scientific article published on September 2006

Comprehensive analysis of glomerular mRNA expression of pro- and antithrombotic genes in atypical haemolytic-uremic syndrome (aHUS) ⬇️

scientific article published on March 9, 2013

Current Diagnostic and Therapeutic Approaches to Patients with Acquired von Willebrand Syndrome: A 2013 Update ⬇️

scientific article published on 08 February 2013

Diagnostic Differentiation of von Willebrand Disease Types 1 and 2 by von Willebrand Factor Multimer Analysis and DDAVP Challenge Test

scientific article published on 21 July 2016

Difficulties in diagnosing congenital thrombotic thrombocytopenic purpura

scientific article

Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura

scientific article

How I treat the acquired von Willebrand syndrome ⬇️

scientific article published on 03 May 2011

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).

scientific article published on 14 March 2008

Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implications

scientific article published on September 2006

Inherited Thrombotic Thrombocytopenic Purpura (Upshaw Schulman Syndrome) as Differential Diagnosis to Neonatal Septicaemia with Disseminated Intravascular Coagulation - a Case Series

scientific article

Inherited thrombotic thrombocytopenic purpura in children

scientific article

Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.

scientific article published on January 2007

Laboratory diagnosis of congenital von Willebrand disease

scientific article

Laboratory testing for von Willebrand disease: contribution of multimer analysis to diagnosis and classification

scientific article published on July 2006

Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease

scientific article published on 20 February 2008

Phenotypic and genotypic diagnosis of von Willebrand disease: a 2004 update

scientific article

Plasmin Cleaves Von Willebrand Factor at K1491-R1492 in the A1-A2 Linker Region in a Shear- and Glycan-Dependent Manner In Vitro

scientific article

Platelet dysfunction and a high bone mass phenotype in a murine model of platelet-type von Willebrand disease

scientific article published on 10 January 2008

Prolonged inhibition of von Willebrand factor-cleaving protease after splenectomy in a 22-year-old patient with acute and plasma refractory thrombotic thrombocytopenic purpura

scientific article

Severe ADAMTS-13 deficiency in childhood

scientific article (publication date: 2004)

Shear-Induced Unfolding and Enzymatic Cleavage of Full-Length VWF Multimers.

scientific article

The mutation N528S in the von Willebrand factor (VWF) propeptide causes defective multimerization and storage of VWF.

scientific article

The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera

scientific article (publication date: September 2006)

Therapeutic plasma exchange and plasma infusion in thrombotic microvascular syndromes

scientific article

Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus).

scientific article

Treatment of acquired thrombotic thrombocytopenic purpura (TTP) with plasma infusion plus rituximab

scientific article

Treatment of the acquired von Willebrand syndrome

scientific article published on December 2015

Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).

scientific article

Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis

scientific article published on April 2014

von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.

scientific article

von Willebrand factor is dimerized by protein disulfide isomerase

scientific article

von Willebrand factor-cleaving protease (ADAMTS13) in the course of stem cell transplantation

scientific article

List of works by Ulrich Budde

A common origin of the 4143insA ADAMTS13 mutation

ADAMTS-13 regulates platelet adhesion under flow. A new method for differentiation between inherited and acquired thrombotic thrombocytopenic purpura.

Acquired von Willebrand syndrome: experience from 2 years in a single laboratory compared with data from the literature and an international registry

Addition of in-vitro generated endothelial microparticles to von-Willebrand plasma improves primary and secondary hemostasis ⬇️

Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences

Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease

Comprehensive analysis of glomerular mRNA expression of pro- and antithrombotic genes in atypical haemolytic-uremic syndrome (aHUS) ⬇️

Current Diagnostic and Therapeutic Approaches to Patients with Acquired von Willebrand Syndrome: A 2013 Update ⬇️

Diagnostic Differentiation of von Willebrand Disease Types 1 and 2 by von Willebrand Factor Multimer Analysis and DDAVP Challenge Test

Difficulties in diagnosing congenital thrombotic thrombocytopenic purpura

Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura

How I treat the acquired von Willebrand syndrome ⬇️

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).

Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implications

Inherited Thrombotic Thrombocytopenic Purpura (Upshaw Schulman Syndrome) as Differential Diagnosis to Neonatal Septicaemia with Disseminated Intravascular Coagulation - a Case Series

Inherited thrombotic thrombocytopenic purpura in children

Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.

Laboratory diagnosis of congenital von Willebrand disease

Laboratory testing for von Willebrand disease: contribution of multimer analysis to diagnosis and classification

Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease

Phenotypic and genotypic diagnosis of von Willebrand disease: a 2004 update

Plasmin Cleaves Von Willebrand Factor at K1491-R1492 in the A1-A2 Linker Region in a Shear- and Glycan-Dependent Manner In Vitro

Platelet dysfunction and a high bone mass phenotype in a murine model of platelet-type von Willebrand disease

Prolonged inhibition of von Willebrand factor-cleaving protease after splenectomy in a 22-year-old patient with acute and plasma refractory thrombotic thrombocytopenic purpura

Severe ADAMTS-13 deficiency in childhood

Shear-Induced Unfolding and Enzymatic Cleavage of Full-Length VWF Multimers.

The mutation N528S in the von Willebrand factor (VWF) propeptide causes defective multimerization and storage of VWF.

The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera

Therapeutic plasma exchange and plasma infusion in thrombotic microvascular syndromes

Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus).

Treatment of acquired thrombotic thrombocytopenic purpura (TTP) with plasma infusion plus rituximab

Treatment of the acquired von Willebrand syndrome

Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).

Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis

von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.

von Willebrand factor is dimerized by protein disulfide isomerase

von Willebrand factor-cleaving protease (ADAMTS13) in the course of stem cell transplantation